Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Application crawled time : 12:00 save search
Clearmind Medicine Files U.S. Patent Application for Psychedelic-Based Treatment for Eating Disorders
Published: 2024-04-10 (Crawled : 12:00) - globenewswire.com
CMND | $1.19 -1.28% 30K
|
n/a
|
| O: -3.03%
H: 7.03%
C: -0.78%
patent disorders treatment for application
Pineapple Financial Inc. to Leverage its Online Application System with Century 21's Largest Brokerage in Canada
Published: 2024-04-08 (Crawled : 12:00) - prnewswire.com
PAPL | $1.36 5.43% 2.94% 44K
|
|
| O: -0.72%
H: 4.38%
C: 0.73%
system canada application financial
NV5 Acquires GIS Solutions, Inc, Enhances Geospatial Application Development and Cloud Services for Departments of Transportation
Published: 2024-04-04 (Crawled : 12:00) - globenewswire.com
NVEE | $91.46 1.62% 1.6% 89K
|
Commercial Services
|
| O: 1.79%
H: 1.25%
C: -0.93%
services cloud application
Can-Fite: Submits FDA with an IND Application to Conduct Phase IIb Clinical Trial of Namodenoson in MASH Patients
Published: 2024-04-03 (Crawled : 12:00) - biospace.com/
CANF | $1.97 -0.51% 0.0% 3.8K
|
Health Technology
|
| O: 2.45%
H: 0.87%
C: -0.43%
fda namodenoson application trial
Next.e.GO N.V. Files Application For Opening Of Insolvency Proceedings
Published: 2024-04-02 (Crawled : 12:00) - globenewswire.com
EGOX | $0.0386 -9.18% -10.1% 12M
|
|
| O: 4.55%
H: 10.03%
C: -13.04%
application
Biosense Webster Submits Application to U.S. FDA Seeking Approval of the VARIPULSE™ Platform for the Treatment of Paroxysmal Atrial Fibrillation
Published: 2024-03-25 (Crawled : 12:00) - prnewswire.com
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: 0.04%
H: 0.0%
C: 0.0%
fda approval treatment application platform
ClearPoint Neuro Congratulates its Partner PTC Therapeutics on Completion of Biologics License Application Submission to FDA for Upstaza™ as a Treatment for AADC Deficiency
Published: 2024-03-19 (Crawled : 12:00) - globenewswire.com
CLPT | $5.505 -0.09% -0.09% 55K
|
Health Technology
|
| O: 0.0%
H: 0.99%
C: -1.27%
fda license treatment application therapeutics submission
IMUNON Files IND Application to Begin Human Testing of IMNN-101
Published: 2024-03-13 (Crawled : 12:00) - globenewswire.com
IMNN | $1.37 7.87% 7.3% 51K
|
Manufacturing
|
| O: -2.15%
H: 3.29%
C: -4.29%
imnn-101 application
Applied UV’s Subsidiary Files Patent Application for New Industry Disruptive Integrated Disinfection System for Healthcare Facilities
Published: 2024-03-11 (Crawled : 12:00) - globenewswire.com
AUVI | $0.5701 -3.55% -3.68% 170K
|
Health Technology
|
| O: 2.16%
H: 3.17%
C: -2.12%
patent system application
SpringWorks Therapeutics Initiates Rolling Submission of New Drug Application to the FDA for Mirdametinib for the Treatment of Children and Adults with NF1-PN
Published: 2024-03-04 (Crawled : 12:00) - globenewswire.com
SWTX | $43.96 2.5% 2.43% 870K
|
Health Technology
|
| O: 0.49%
H: 0.12%
C: -2.95%
fda drug children treatment application therapeutics submission
Cullinan Oncology Announces U.S. FDA Clearance of Investigational New Drug Application for Novel MICA/B Antibody, CLN-619, for Relapsed/Refractory Multiple Myeloma
Published: 2024-03-01 (Crawled : 12:00) - globenewswire.com
CGEM | $16.645 6.49% 6.07% 970K
|
|
| O: 3.41%
H: 0.42%
C: -3.09%
cln-619 fda drug clearance application
ASLAN Pharmaceuticals Receives Favorable Opinion From the European Patent Office on Composition of Matter Patent Application for Farudodstat
Published: 2024-02-29 (Crawled : 12:00) - globenewswire.com
ASLN | News | $0.4645 2.09% 2.05% 1.5M
|
Health Technology
|
| O: 2.86%
H: 25.0%
C: 22.22%
patent favorable pharmaceuticals application
BeiGene’s Biologics License Application for TEVIMBRA® (tislelizumab) for First-Line Gastric or Gastroesophageal Junction Cancers Accepted by FDA
Published: 2024-02-27 (Crawled : 12:00) - biospace.com/
BGNE | $139.22 6.32% 5.95% 200K
|
Health Technology
|
| O: 2.93%
H: 9.05%
C: 8.94%
tevimbra fda license application
New Veeva Vault Submissions Publishing eLearning Application Speeds Employee Onboarding
Published: 2024-02-12 (Crawled : 12:00) - prnewswire.com
VEEV | $201.1 1.03% 0.0% 900K
|
Technology Services
|
| O: 0.01%
H: 1.57%
C: 0.77%
application employee
Krystal Biotech Announces Publication in the New England Journal of Medicine on the Application of B-VEC to Treat Ocular Complications in Patient with Dystrophic Epidermolysis Bullosa
Published: 2024-02-08 (Crawled : 12:00) - globenewswire.com
KRYS | News | $162.175 3.13% 3.04% 220K
|
Health Technology
|
| O: 0.27%
H: 1.07%
C: -0.41%
biotech ocular publication treat application
BioXcel Therapeutics Announces USPTO’s Allowance of Patent Application for Method of Treating Agitation in Alzheimer’s Disease Using Oromucosal Formulations of Dexmedetomidine
Published: 2024-02-05 (Crawled : 12:00) - globenewswire.com
BTAI | News | $2.965 4.04% 3.88% 410K
|
Health Technology
|
| O: 9.48%
H: 15.37%
C: 10.75%
patent disease alzheimer’s application therapeutics
Tisotumab Vedotin Marketing Authorization Application Validated by European Medicines Agency for Treatment of Recurrent or Metastatic Cervical Cancer
Published: 2024-02-02 (Crawled : 12:00) - globenewswire.com
GNMSF | News | $289.67 3.83% 5.3K
|
Health Technology
|
| O: -0.78%
H: 0.3%
C: -0.84%
PFE | News 4 | $26.32 0.23% 0.0% 24M
|
Health Technology
|
| O: -0.4%
H: 0.07%
C: -0.92%
GMAB | News | $28.54 -1.48% -1.51% 560K
|
Health Technology
|
| O: -1.21%
H: 0.72%
C: -0.11%
authorization cancer treatment application
Apellis Announces Negative CHMP Opinion for Pegcetacoplan for GA in the European Union and Plans to Seek Re-Examination of Application
Published: 2024-01-26 (Crawled : 12:00) - globenewswire.com
APLS G | $48.69 2.2% 2.16% 1.2M
|
Health Technology
|
| O: -0.35%
H: 0.41%
C: -3.0%
chmp application negative
Autolus Therapeutics announces acceptance of Biologics License Application for obecabtagene autoleucel (obe-cel) as a potential treatment for relapsed/refractory Adult B-cell Acute Lymphoblastic Leukemia (ALL)
Published: 2024-01-22 (Crawled : 12:00) - globenewswire.com
AUTL | $4.5 -1.32% -1.33% 1.7M
|
Health Technology
|
| O: 2.45%
H: 2.72%
C: -8.15%
license treatment application leukemia therapeutics potential
TIVDAK® (tisotumab vedotin-tftv) Supplemental Biologics License Application Accepted for Priority Review by U.S. Food and Drug Administration for Patients with Recurrent or Metastatic Cervical Cancer
Published: 2024-01-09 (Crawled : 12:00) - globenewswire.com
GNMSF | News | $289.67 3.83% 5.3K
|
Health Technology
|
| O: -3.69%
H: 1.71%
C: -2.41%
PFE | News 4 | $26.32 0.23% 0.0% 24M
|
Health Technology
|
| O: 0.07%
H: 0.88%
C: -0.68%
GMAB | News | $28.54 -1.48% -1.51% 560K
|
Health Technology
|
| O: -1.1%
H: 0.46%
C: -0.06%
tivdak drug license review food cancer application
Gainers vs Losers
| 78% | 22% |
Top 10 Gainers
MTTR | News 4 | $4.6 164.37% 62.17% 28M
|
AGBA | $2.94 135.2% 57.48% 66M
|
Finance
EDBL | News | $6.46 71.81% 41.8% 2M
|
MTC | $2.25 44.23% 30.67% 6M
|
Technology Services
OPRT | News | $3.175 41.11% 29.13% 12M
|
Finance
SHIM | $3.05 35.56% 26.23% 1.1M
|
HKIT | $1.345 31.86% 24.16% 390K
|
Technology Services
ABVC | $1.36 30.77% 23.53% 7.4M
|
Wholesale Trade
OST | $0.512 28.0% 21.88% 290K
|
POET | $1.59 27.2% 21.38% 4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.